Related coverage linked through entity extraction aliases.
Aug 24, 2026
Everything Sprouts LLC recalled alfalfa sprouts after 55 E. coli and Salmonella illnesses in 15 states. Four people were hospitalized; no deaths were reported. Consumers should discard affected products.
Aug 15, 2026
Real-world studies show nirsevimab reduced RSV infant hospitalizations by up to 72% and maternal vaccination cut hospitalizations by nearly 70%, with benefits extending into the second RSV season.
Aug 13, 2026
A 19-month-old girl with influenza A (H1N1)-associated acute necrotizing encephalitis made a complete neurological recovery despite a severity score of 6. Multimodal immunomodulatory therapy including IVIG, corticosteroids, anakinra, and plasma exchange led to rapid decline in blood cytokine levels. The case underscores early recognition and targeted treatment in young children.
Jul 20, 2026
New research reveals how TB bacteria resist drugs via PE/PPE proteins and evade immune defenses by stiffening cell membranes. TB remains the leading infectious killer, with 1.23 million deaths in 2024.
Aug 08, 2026
New research highlights strategies to overcome cancer drug resistance: a triple-drug AML combination, a breast cancer resistance target, evolutionary treatment switching, DNA damage mechanisms, and sildenafil's anti-metastatic potential.
May 17, 2026
Tracy Beth Hoeg, the FDA's acting drug center director, has been removed from her role after leading reviews of antidepressants, COVID-19 vaccines and RSV drugs. She is replaced by Dr. Mike Davis, as the agency continues a leadership shake-up.
Apr 28, 2026
A multistate outbreak of highly drug-resistant Salmonella has been linked to moringa powder capsules, with seven infections across seven states. Three people have been hospitalized, and Ambrosia Brands, LLC has voluntarily recalled specific lots of Rosabella-brand moringa capsules.
Jun 19, 2026
FDA's vaccine advisory committee unanimously recommended Moderna's mRNA flu vaccine mFlusiva for adults 50 and over, the committee's first new vaccine review since 2023. The FDA expects an approval decision by Aug 5, 2026.
May 28, 2026
The Trump administration barred NIAID officials from WHO meetings, reclaimed $600M from four states, and faced a Senate report showing drug prices rising despite deals. New drugs average $353K a year.
May 27, 2026
President Trump has terminated the EPA's endangerment finding, stripping federal authority to limit greenhouse gas pollution. The move could add up to 18 billion metric tons of climate pollution by 2055, potentially causing 184,000 early deaths and 37 million asthma attacks. Legal challenges are expected from Democratic leaders and environmental groups.
Aug 09, 2026
The FDA approved Moderna's mFlusiva, the first mRNA-based flu vaccine, for adults 50 and older. Full approval covers ages 50-64; accelerated approval covers 65+. Moderna expects availability later this year, pending CDC recommendation.
Jul 08, 2026
A randomized trial showed Cepheid's Xpert Xpress MVP point-of-care test improved appropriate treatment for vaginitis within 24 hours. Other modeling found treating male partners of women with bacterial vaginosis reduced recurrence and was cost-saving.
May 08, 2026
Recent studies highlight progress in monoclonal antibodies against measles, Lyme disease, and Epstein-Barr virus. A Phase I Lyme antibody trial showed lasting protection, while preclinical antibodies blocked EBV and measles infection.
Jul 24, 2026
The European Medicines Agency is enforcing clinical trial transparency and has launched a new vaccine information initiative, while a coalition of health professionals warns of suboptimal vaccination coverage across Europe. An analysis also shows that only a portion of EMA-approved medicines are available to NHS patients in England after additional assessments.
Jul 10, 2026
Study links MMR hesitancy to right-leaning media and alternative health sources. As US measles cases top 2,000, New Jersey confirms its first case of the year and urges vaccination.
Jul 09, 2026
Two new studies in IBD genetics show that polygenic risk scores can predict disease severity in Danish patients, and that ancestry-specific variants in Hispanic populations reveal novel risk loci and differential effects of known genes. These findings advance precision medicine by improving risk prediction and highlighting the need for diverse genetic research.
Jul 18, 2026
Three infant botulism cases prompted Nara Organics to recall its organic formula. Federal records also show formula makers sent no death reports to the FDA in 26 years, and separate tests found PFAS and patulin.
Jun 10, 2026
Trial: VPM1002/Immuvac show limited overall TB protection but up to 50.4% efficacy vs extrapulmonary TB. Modeling: blocking asymptomatic TB key to long-term vaccine impact. Also: STEP-TB safety study and CDC Asia funding.
Jul 25, 2026
CDC and FDA are investigating a multistate outbreak of drug-resistant Salmonella linked to Rosabella moringa capsules. Seven people in seven states are infected; three hospitalized; no deaths.
Jul 08, 2026
CDC suppressed COVID-19 vaccine data; federal agencies may remove vaccines from the US market. Clinicians cite a JAMA study: 40% efficacy against hospitalization, 79% against severe outcomes.
